HTFL (HeartFlow) Business Value to Revenue

Public company logo of heartflow.com (HTFL)

Heartflow Inc relies on cloud hosting for vascular analysis, isolating its R&D developments. Despite pressure from medtech behemoths, outsourcing IT infrastructure to external providers allows the company to focus on refining its algorithms. The total cost-to-revenue ratio visualizes the valuation trend, where the value 16304.99 serves as a baseline indicator for analyzing whether the capitalization is overheated relative to the business's actual earnings.

HTFL heartflow.com: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/19/2026

HeartFlow, Inc. - analytical breakdowns and key metrics (HTFL)

- market value and analyst target forecast:
- business market valuation indicators:
Fundamental valuation:HeartFlow Medical (HTFL)
Manufactured product of HeartFlow

To minimize the risk of overpaying for the asset, it is necessary to analyze the enterprise value of the business, accounting for net debt relative to its annual revenue. The current EV/Sales ratio stands at 16304.99, reflecting a high premium for the technological leadership of Heartflow Inc. (HTFL) in the field of AI diagnostics and the growing confidence of the global medical community in blood flow analysis methods.